Bingqiang Ni

Seven Hub Genes Predict the Prognosis of Hepatocellular Carcinoma and the Corresponding Competitive Endogenous RNA Network

Jianxun Lu, Xueqiong Han, Chun Chen, 2022, Journal of oncology.

HOXC10 promotes cell migration, invasion, and tumor growth in gastric carcinoma cells through upregulating proinflammatory cytokines

Ying Zhang, Boran Cheng, Xuan Wu, 2020, Journal of cellular physiology.

Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐cell lung cancer: A multicenter, randomized, double‐blinded, phase III trial

H. Pan, Yanqiu Zhao, P. Xing, 2021, Cancer communications.

Implications of inflammatory cell death-related IFNG and co-expressed RNAs (AC006369.1 and CCR7) in breast carcinoma prognosis, and anti-tumor immunity

M. Pan, Zhenlong Li, Xueqiong Han, 2023, Frontiers in Genetics.

Systematic pan-cancer analysis insights into ICAM1 as an immunological and prognostic biomarker.

Huayun Wu, Zhenlong Li, Bingqiang Ni, 2024, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Raltitrexed plus oxaliplatin-based transarterial chemoembolization in patients with unresectable hepatocellular carcinoma

Jianxun Lu, Changsheng Chen, Zhiyong Zheng, 2016, Anti-cancer drugs.